Projected benefits of universal or scheduled antepartum corticosteroids to prevent neonatal morbidity: a decision analysis

Am J Obstet Gynecol. 2005 Oct;193(4):1415-23. doi: 10.1016/j.ajog.2005.03.062.

Abstract

Objective: The purpose of this study was to compare strategies of corticosteroid administration for the prevention of neonatal morbidity and death.

Study design: A Markov decision model compared 3 strategies of antepartum corticosteroid administration: (1) to all pregnant women (universal), (2) to all pregnant women with a previous preterm delivery (high risk), and (3) to women who had preterm labor symptoms that placed them at risk for delivery within 7 days (current). A second model with addition of a "rescue" arm to capture women who remained undelivered was also created.

Results: Compared with the current strategy, the universal strategy would result in roughly 1000 fewer cases of respiratory distress syndrome and > 3 million more women would receive corticosteroids annually. The addition of a rescue arm further reduces morbidity and mortality rates.

Conclusion: A universal strategy of corticosteroid administration confers potential benefit for the prevention neonatal morbidity or death over the current strategy but requires that a large number of women be treated.

Publication types

  • Comparative Study
  • Research Support, N.I.H., Extramural
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adrenal Cortex Hormones / therapeutic use*
  • Decision Support Techniques*
  • Female
  • Humans
  • Infant, Newborn
  • Infant, Newborn, Diseases / mortality
  • Infant, Newborn, Diseases / prevention & control*
  • Markov Chains
  • Pregnancy
  • Risk Factors
  • Sensitivity and Specificity

Substances

  • Adrenal Cortex Hormones